The spectrum of multiple myeloma: Diagnostic and biological implications

Human Pathology

Volumn 28, Issue 12, 1997, Pages 1336-1347

  Larson, Richard S ^a,b   Sukpanichnant, Sanya ^c   Greer, John P ^c   Cousar, John B ^c   Collins, Robert D ^c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c NONE

Author keywords

Bone marrow; Histology; Immunohistochemistry; Multiple myeloma; Pathology; Plasma cells

Indexed keywords

ADULT; AGED; BONE MARROW BIOPSY; CANCER GROWTH; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMA CELL; REVIEW; RISK FACTOR;

EID: 0031437251     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90221-5     Document Type: Article

References (53)

1. Clamp JR: Some aspects of the first recorded case of multiple myeloma. Lancet 2:1354-1356, 1967
2. Sukpanichnant S, Cousar JB, Leelasiri A, et al: Diagnostic criteria and histologic grading in multiple myeloma: Histologic and immunophenotypic analysis of 176 cases with clinical correlation. HUM PATHOL 25:308-318, 1994
3. Sailer M, Vykoupil K-F, Peest D, et al: Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol 54:137-146, 1995
4. Bartl R, Frish B, Fateh-Moghadam A, et al: Histologie classification and staging of multiple myeloma: A retrospective and prospec-tive study of 674 cases. Am J Clin Pathol 87:342-355, 1987
5. Cavo M, Baccarani M, Gobbi M, et al: Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma. Br J Haematol 55:683-690, 1983
6. Bartl R, Frisch B, Diem MD, et al: Histologic, biochemical, and clinical parameters for monitoring multiple myeloma. Cancer 68:2241-2250, 1991
7. Carbonne A, Volpe R, Manconi R, et al: Bone marrow pattern and clinical staging in multiple myeloma: Correspondence. Br J Haematol 65:502-503, 1985
8. Murakami H, Nemoto K, Sawamura M, et al: Prognostic relevance of morphological classification in multiple myeloma. Acta Haematol 87:113-117, 1992
9. Bard R, Frisch B, Burkhardt R, et al: Bone marrow histology in myeloma: Its importance in diagnosis, prognosis, classification and staging. Br J Haematol 51:361-375, 1982
10. Bartl R, Frisch B, Wilmanns W: Morphology of multiple myeloma, in Malpas JS, Bergsagel DE, Kyle RA (eds) : Myeloma Biology and Management (ed 1). New York, NY, Oxford University Press, 1995, pp 127-168
11. Greipp PR, Raymond NM, Kyle RA, et al: Multiple myeloma: Significance of plasmablastic subtype in morphological classification. Blood 65:305-310, 1985
12. Paule B, Quilard J, Bisson MF, et al: Prognostic significance of plasma cell morphology in multiple myeloma. Nouv Rev Fr Hematol 30:209-212, 1988
13. MeisJM, Butler JJ, Osborne BM, et al: Solitaryplasmacytomas of bone and extramedullary plasmacytomas: A clinicopathologic and immunohistochemical study. Cancer 59:1475-1485, 1987
14. Corwin J, Lindberg RD: Solitary plasmacytoma of bone vs. extramedullary plasmacytoma and their relationship to multiple myeloma. Cancer 43:1007-1013, 1979
15. Wiltshaw E: The natural history of extramedullary plasmacytoma and its relationship to solitary myeloma of bone and myelomatosis. Medicine 55:217-238, 1976
16. Kyle RA: Benign monoclonal gammopathy: A misnomer? JAMA 251:1849-1854, 1984
17. Griepp PR: Monoclonal gammopathies: New approaches to clinical problems in diagnosis and prognosis. Blood Rev 3:222-236, 1989
18. Riccarki A, Gobbi PG, Ucci G, et al: Changing clinical presentation of multiple myeloma. Eur J Cancer 27:1401-1405, 1991
19. Kyle RA: Multiple myeloma: Review of 869 cases. Mayo Clin Proc 50:29-40, 1975
20. MalpasJS: Clinical presentation and diagnosis, in Malpas JS, Bergsagel DE, Kyle RA (eds): Myeloma Biology and Management (ed 1). New York, NY, Oxford University Press, 1995, pp 127-168
21. Janeway CA, Travers P: Immunobiology: The Immune System in Health and Disease. Philadelphia, PA, Current Biology Ltd., 1994
22. Liu YJ, Josha DE, Williams GT, et al: Mechanism of antigendriven selection in germinal centres. Nature 342:929-931, 1989
23. Tew JG, DiLosa RM, Burton GF, et al: Germinal centers and antibody production in bone marrow. Immunol Rev 126:99-112, 1992
24. Seiden MV, Anderson KC: Multiple myeloma. Curr Opin Oncol 6:41-49, 1994
25. Bakkus MHC, Heirman C, Van-Reit I, et al: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic muta-tions but show no intraclonal variation. Blood 80:2326-2335, 1992
26. Jensen GS, Belch AR, Kherani F, et al: Restricted expression of immunoglobulin light-chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Scand J Immunol 36:843-850, 1992
27. Corradini P, Boccadoro M, Voena C, et al: Evidence for a bone marrow B-cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas. J Exp Med 178:1091-1096, 1993
28. Reis LAG, Hankey BF, Miller BA, et al: Cancer statistics reviews 1973-88. NIH publication No. 91-2789. Bethesda, MD, National Cancer Institute, 1991
29. Wu S, Brady K, Anderson JJ, et al: The predictive value of bone marrow morphologic characteristics and immunostaining in primary (AL) amyloidosis. Am J Clin Pathol 96:95-99, 1991
30. Wolf BC, Kumar A, Vera JG, et al: Bone marrow morphology and immunology in systemic amyloidosis. Am J Clin Pathol 86:84-88, 1986
31. Falini B, Solas ID, Levine AM, et al: Emergence of B-immunoblastic sarcoma in patients with multiple myeloma: A clinicopathologic study of 10 cases. Blood 5:923-932, 1982
32. Schneider DR, Taylor DR, Parker JW, et al: Immunoblastic sarcoma of T and B cell types: Morphologic description and comparison. HUM PATHOL 16:885-900, 1985
33. Strand WR, Banks PM, Kyle RA: Anaplastic cell myeloma and immunoblastic lymphoma: Clinical, pathologic, and immunologic comparison. Am J Med 76:861-867, 1984
34. Stricker JG, Audech MW, Copenhaver CM, et al: Immunophenotypic differences between plamacytoma/multiple myeloma and immunoblastic lymphoma. Cancer 61:1782-1786, 1988
35. Driedger H, Pruzanski W: Plasma cell neoplasms with osteosclerotic lesions: A study of five cases and a review of the literature. Arch Intern Med 139:144-148, 1979
36. Bataille R, Chappard D, Marcelli C, et al: Osteoblast stimulation in multiple myeloma lacking lytic bone lesions. Br J Haematol 76:484-487, 1990
37. Valentin-Opran A, Charhon SA, Meunier PJ, et al: Quantitative histology of myeloma-induced bone changes. Br J Haematol 52:601-610, 1982
38. Bataille R, Chappard D, Marcelli C, et al: Mechanisms of bone destruction in multiple myeloma: The importance of an unbalanced process in determining severity of lytic bone disease. J Clin Oncol 7:1909-1914, 1989
39. Bataille R, Chappard D, Klein B: Mechanisms of bone lesions in multiple myeloma. Hematol Oncol Clin North Am 6:285-295, 1992
40. Sullivan PV, Salman SE: Kinetics of tumor growth and regression in IgG multiple myeloma. J Clin Invest 51:1697-1708, 1972
41. Levine SB, Bernstein LD: Crystalline inclusions in multiple myeloma. JAMA 254:1985, 1985
42. Osterborg A, Mellstedt H: Monoclonal and biclonal immunoglobulin-producing disorders. Eur J Haematol 51:11-18, 1989
43. Cavo M, Galieni P, Gobbi M, et al: Non-secretory multiple myeloma: Presenting findings, clinical course, and prognosis. Acta Haematol 74:27-30, 1985
44. Sone Y, Kawano F, Nishimura Y, et al: Natural type interferon-alpha therapy for multiple myeloma complicated by hemolytic anemia. Jpn J Clin Hematol 34:670-672, 1993
45. Lai KN, Chan KW, Siu DL, et al: Pathologic hip fracture secondary to amyloidoma: Case report and review of literature. Am J Med 77:937-940, 1984
46. Lowell D: Amyloid producing plasmacytoma of the pelvis. Arch Surg 94:899-901, 1967
47. Bardwick PA, Zvaifler NJ, Gill GN, et al: Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: The POEMS syndrome. Medicine (Baltimore) 59:311-322, 1980
48. Read D, Warlow C: Peripheral neuropathy and solitary plasmacytoma. J Neurol Neurosurg Psychiatry 41:177-184, 1978
49. MorleyJB, Schweiger AC: The relation between chronic polyneuropathy and osteosclerotic myeloma. J Neurol Neurosurg Psychiatry 30:432-442, 1967
50. Victor M, Banker BQ, Adams RD: The neuropathy of multiple myeloma. J Neurol Neurosurg Psychiatry 21:73-78, 1958
51. Larson RS, Springer TA: Leukocyte integrins. Immunol Rev 114:178-217, 1990
52. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314, 1994
53. Sanders PW, Herrera GA, Kirk KA, et al: Spectrum of glomer-ular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 64:527-537, 1991